Medacta Group revenue and financials
CHF 114.60Change from previous close: 0.00%Absolute change: +CHF 0.00
In the fiscal year ended December 2025, Medacta Group reported revenue of €683.83M (+15.79% year over year). Net income was €95.46M, a net margin of 14.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +15.79%
- 2025 vs 2024
- Net income growth
- +30.97%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 12.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q2 2025 |
|---|---|---|
| Total assets | 918 | 861 |
| Current assets | 450 | 442 |
| Cash and equivalents | 33.2 | 33.2 |
| Short-term investments | — | 7.4 |
| Inventory | 271 | 267 |
| Net property, plant and equipment | 386 | 343 |
| Goodwill | 0.1 | — |
| Other intangible assets | 61.6 | — |
| Current liabilities | 217 | 185 |
| Accounts payable | 49.8 | 51.0 |
| Long-term debt | 114 | — |
| Total debt | 261 | 51.1 |
| Total liabilities | 461 | 436 |
| Total equity (incl. minority) | 457 | 425 |
| Retained earnings | 434 | 398 |